医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

OnCore Manufacturing Receives ISO13485 Certification and IPC J-STD-001 QML/ Qualified Manufacturer List at its Suzhou, China facility

2015年02月19日 PM12:00
このエントリーをはてなブックマークに追加


 

FREMONT, Calif.

OnCore Manufacturing, LLC, a global supplier of electronic manufacturing services, announces that its manufacturing facility in Suzhou, China has been certified to ISO 13485:2012 quality management system for medical devices. The OnCore Suzhou site has also been certified by IPC to J-STD-001/IPC-A-610 Qualified Manufacturers List (QML) for electronics assembly.

ISO13485 outlines a comprehensive quality management system for the design and manufacture of medical devices. Achieving certification demonstrates a commitment for quality throughout the product development life-cycle of medical devices.

Achievement of the IPC QML requires passing an intensive audit process to IPC J-STD-001 standard that describes materials, methods and verification criteria for producing high quality soldered interconnections, and IPC-A-610, Acceptability of Electronic Assemblies. OnCore Suzhou is one of only two manufactures in China to achieve the QML certification.

“The recent certification brings all eight of OnCore Manufacturing sites to ISO 13485 compliance,” stated David Busch, OnCore Vice President Medical. “It demonstrates OnCore’s commitment to expanding our service offering for medical manufacturing with consistent processes at any of the OnCore sites worldwide.”

“Completing these new milestones at our recently expanded Suzhou China location demonstrates OnCore’s industry quality leadership and also creates alignment of our strategy with our customers seeking China medical product manufacturing,” says David Brakenwagen, OnCore Manufacturing Senior Vice President of Sales and Marketing.

About OnCore

OnCore Manufacturing, LLC is a leading provider of product commercialization services for low-medium volume, high-complexity products to international blue-chip aerospace and defense, industrial, and medical companies. With manufacturing facilities in Springfield and Wilmington, MA, Longmont, CO, San Marcos and Fremont, CA, Suzhou, China and Tijuana, Mexico, OnCore manages customers’ high-complexity products while providing them maximum flexibility to manage their business in a close, collaborative relationship. More information is available at www.oncorems.com. OnCore is an equal opportunity employer.

CONTACT

OnCore Manufacturing, LLC
Steve Heinzen, 510-933-6065
VP
Marketing
steve.heinzen@oncorems.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing
  • 三叶草生物制药完成6,280万元人民币A轮融资
  • Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.
  • Walmart, JD.com, IBM and Tsinghua University Launch a Blockchain Food Safety Alliance in China
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表